Up to 70% fatal
Associated with increased risk of hospitalization and death
On the 2nd, a corona 19 announcement appeared in London, England. London = EPA Yonhap News
A study by the UK government found that the U.K. novel coronavirus infection (Corona 19) mutant virus not only has a stronger transmission power than the existing virus, but also has a mortality rate of up to 70%.
According to the Washington Post (WP) on the 14th (local time), researchers from the UK government announced the results that the UK mutation is 30-70% more lethal than the existing Corona 19 virus. British Prime Minister Boris Johnson said at a press conference in response to Corona 19 on the 22nd of last month, “Not only is the mutation spreading more quickly, but it seems to be linked to a higher fatality rate.”
The study was conducted by scientists from the UK’s New Respiratory Virus Threat Advisory Group (NERVTAG) gathering data on infected people across the UK. As a result of the analysis, those infected with the British mutation were more severely ill and more likely to go to the hospital. The report noted that “compared to other corona19 viruses, the UK mutation was associated with an increased risk of hospitalization and death.”
The British mutation spread rapidly in some regions, including the capital London and southeastern England, in October last year, and is now spreading to 80 countries. At the time of discovery, the British government explained that “the spread of the mutation can be up to 70% stronger than that of the existing virus, but there is no evidence that it has a high fatality rate or affects the vaccine.” However, as the number of mutant infections increases, further analysis has emerged to reverse this.
It is also predicted that in the UK on this day, a’universal vaccine’ will be developed that can prevent all COVID-19 mutations in one year. According to the British newspaper Telegraph, a research team at the University of Nottingham is developing a vaccine that works against all mutations targeting the core, not the coronavirus spiky protein. It is known that some companies in Europe and the US are also doing related research.
Heo Gyeongju reporter [email protected]
Subscribe to the Hankook Ilbo News Naver Channel
The balance of seeing the world Copyright © Hankookilbo